Malicki, S.; Pucelik, B.; Żyła, E.; Benedyk-Machaczka, M.; Gałan, W.; Golda, A.; Sochaj-Gregorczyk, A.; Kamińska, M.; Encarnação, J.C.; Chruścicka, B.;
et al. Imaging of Clear Cell Renal Carcinoma with Immune Checkpoint Targeting Aptamer-Based Probe. Pharmaceuticals 2022, 15, 697.
https://doi.org/10.3390/ph15060697
AMA Style
Malicki S, Pucelik B, Żyła E, Benedyk-Machaczka M, Gałan W, Golda A, Sochaj-Gregorczyk A, Kamińska M, Encarnação JC, Chruścicka B,
et al. Imaging of Clear Cell Renal Carcinoma with Immune Checkpoint Targeting Aptamer-Based Probe. Pharmaceuticals. 2022; 15(6):697.
https://doi.org/10.3390/ph15060697
Chicago/Turabian Style
Malicki, Stanisław, Barbara Pucelik, Edyta Żyła, Małgorzata Benedyk-Machaczka, Wojciech Gałan, Anna Golda, Alicja Sochaj-Gregorczyk, Marta Kamińska, João Crispim Encarnação, Barbara Chruścicka,
and et al. 2022. "Imaging of Clear Cell Renal Carcinoma with Immune Checkpoint Targeting Aptamer-Based Probe" Pharmaceuticals 15, no. 6: 697.
https://doi.org/10.3390/ph15060697
APA Style
Malicki, S., Pucelik, B., Żyła, E., Benedyk-Machaczka, M., Gałan, W., Golda, A., Sochaj-Gregorczyk, A., Kamińska, M., Encarnação, J. C., Chruścicka, B., Marti, H. -P., Chen, T. J., Magiera-Mularz, K., Zięba, B., Holak, T. A., Dąbrowski, J. M., Czarna, A., Kozieł, J., Mydel, P.,
& Dubin, G.
(2022). Imaging of Clear Cell Renal Carcinoma with Immune Checkpoint Targeting Aptamer-Based Probe. Pharmaceuticals, 15(6), 697.
https://doi.org/10.3390/ph15060697
